Why to attend

Why to attend ISCO 25?

Attending ISCO 25, the annual congress organized by the International School of Clinical Oncology (ISCO), offers several valuable benefits for oncologists and professionals in the field:

1. Knowledge and Education: ISCO 25 provides a platform for oncologists to expand their knowledge and stay updated with the latest advancements in clinical oncology. The congress features eminent speakers from all around the globe who present the most up-to-date data on clinical trials, research findings, and cancer management.
2. Networking and Collaboration: ISCO 25 brings together oncologists and professionals from various countries and institutions, creating a conducive environment for networking and collaboration.
3. Exposure to New Clinical Programs: The congress promotes the exchange of clinical programs, allowing attendees to learn about innovative approaches and practices being implemented in different regions.
4. Access to Cutting-Edge Research: ISCO 25 provides updates on the latest research in clinical trials and progress against cancer.
5. Professional Development: ISCO 25 is a continuous medical and clinical education platform. The knowledge acquired at ISCO 25 can be applied to improve patient care, decision-making, and overall practice in oncology.